Fair Value Calculator Fair Value Calculator
EN DE

INTEGRAEN (INTEGRAEN) Fair Value & Analysis

IN · Market cap ₹7.5B

I INTEGRAEN INTEGRAEN · BSE
Price₹217.55
Fair Value₹89.59
Upside-58.8%
Quality59/100
Watch INTEGRAEN for free — get notified when fair value or trend changes. Watch for free
Evidence: High Range ₹55.82 – ₹111.99

Fair value as of: Jul 5, 2026

From 26 valuation models · updated today

Share price −0.7% over the past month.

Price vs Fair Value (12 months)

₹273.00 ₹119.05 Fair Value ₹89.59 Jul 2025 Jul 2026

12‑month range ₹119.05 – ₹273.00 · fair‑value band ₹55.82 – ₹111.99 · the ₹217.55 price screens above the ₹89.59 fair value. As of Jul 5, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

INTEGRAEN (INTEGRAEN) currently trades at ₹217.55, while our model-based Fair Value estimate is ₹89.59 — implying the stock looks roughly 58.8% overvalued today. We read business quality at 59/100 (solid quality). Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

Over the trailing twelve months, INTEGRAEN generated revenue of ₹1.7B at a net margin of 9.1%. Revenue declined 9.7% year over year. It earns a return on equity of 14.9%. Net debt stands at ₹204M. Fundamentals as of Jul 5, 2026

Our scenario range runs from ₹55.82 (bear case) to ₹111.99 (bull case); at ₹217.55, the current price sits above that range. The share trades about 22% below its 52-week high and 84% above its 52-week low, currently above its 200-day average.

Key figures & financial health

Revenue (TTM) ₹1.7B
Revenue growth (YoY) -9.7%
Net margin 9.1%
Return on equity 14.9%
Free cash flow ₹98.9M FY2026
P/E ratio 48.6
More key figures
Operating margin 10.0%
EPS (TTM) ₹4.48
EPS growth (YoY) -43.3%
Net debt ₹204M FY2026

Figures from reported company fundamentals (EODHD) · as of Jul 5, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

INTEGRAEN reported revenue of ₹1.6B in FY2026 versus ₹973M in FY2022, a compound +13.8%/yr. Reported net income was ₹154M in FY2026, compounding +14.1%/yr from FY2022.

Revenue +13.8%/yr
FY22 ₹973M
FY23 ₹1.3B
FY24 ₹1.4B
FY25 ₹1.6B
FY26 ₹1.6B
Net income +14.1%/yr
FY22 ₹91.0M
FY23 ₹182M
FY24 ₹145M
FY25 ₹185M
FY26 ₹154M

Is INTEGRAEN fairly valued? → Check now

🧮 Run the numbers yourself — free valuation calculators
📤 Share or link this analysis
🔗 Embed on your site (free fair-value badge)

Paste this into your site or blog — it shows the current fair value and links back here (free, and welcome):

Cite: Fair Value Calculator (2026). "INTEGRAEN Fair Value". https://www.fairvalue-calculator.com/stock/INTEGRAEN

Explore undervalued stocks

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is INTEGRAEN (INTEGRAEN) undervalued?
As of Jul 5, 2026, our model estimates a fair value of ₹89.59 versus a price of ₹217.55 — about −59% (overvalued). Model-based estimate, not financial advice.
What is the fair value of INTEGRAEN?
Our model-based fair value for INTEGRAEN is ₹89.59 (as of Jul 5, 2026), built from audited fundamentals. The current price is ₹217.55.
What is the quality score of INTEGRAEN?
INTEGRAEN has a Quality Score of 59/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of INTEGRAEN (INTEGRAEN)?
INTEGRAEN reported trailing-twelve-month revenue of about ₹1.7B (latest available figure, as of Jul 5, 2026).
What is the net profit margin of INTEGRAEN?
The net profit margin of INTEGRAEN is about 9.1%, meaning it keeps roughly 9.1% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.